by Brenda Baletti, Ph.D., Childrens Health Defense:

Freedom of Information Act documents obtained by Children’s Health Defense reveal that two infants died the same day they received nirsevimab, marketed under the brand name Beyfortus, a monoclonal antibody shot approved last year for infants for the prevention of RSV.

At least two infant deaths reported to the Vaccine Adverse Event Reporting System (VAERS) as occurring after the babies mistakenly received Pfizer’s adult respiratory syncytial virus (RSV) vaccine were likely caused instead by nirsevimab, the monoclonal antibody shot approved for infants and meant to prevent RSV.